Literature DB >> 10702707

Time-related effects of cytomegalovirus infection on the development of chronic renal allograft rejection in a rat model.

I Lautenschlager1, A Soots, L Krogerus, K Inkinen, J Kloover, R Loginov, K Holma, H Kauppinen, C Bruggeman, J Ahonen.   

Abstract

Cytomegalovirus (CMV) infection is a risk factor for chronic allograft rejection. The histological findings of chronic renal allograft rejection include inflammation, vascular intimal thickening, glomerulosclerosis, tubular atrophy and fibrosis. We have developed a rat model of renal transplantation in which transplants, after an early inflammatory episode, end up with chronic rejection within 60 days. During the early phase of the process in this model, CMV increased and prolonged the inflammatory response, the expression of adhesion molecules, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 and their ligands, lymphocyte function antigen-1 and very late antigen-4 in the graft. Simultaneously, the production of various growth factors, such as transforming growth factor beta, platelet-derived growth factor and connective tissue growth factor was upregulated, which induce smooth muscle cell proliferation in the vascular wall and collagen synthesis by fibroblasts. Chronic rejection developed within 20 days in CMV-infected grafts. In summary, CMV infection accelerated and enhanced the early immune response, the induction of growth factors and collagen synthesis, and the development of chronic rejection in renal allografts. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10702707     DOI: 10.1159/000053961

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  8 in total

1.  Allograft rejection-related gene expression in the endothelial cells of renal transplantation recipients after cytomegalovirus infection.

Authors:  Yang Li; Hang Yan; Wu-jun Xue; Pu-xun Tian; Xiao-ming Ding; Xiao-ming Pan; Xin-shun Feng; Xiao-hui Tian; He-li Xiang; Jun Hou
Journal:  J Zhejiang Univ Sci B       Date:  2009-11       Impact factor: 3.066

2.  Ganciclovir prophylaxis improves late murine cytomegalovirus-induced renal allograft damage.

Authors:  Masako Shimamura; Maria C Seleme; Lingling Guo; Ute Saunders; Trenton R Schoeb; James F George; William J Britt
Journal:  Transplantation       Date:  2013-01-15       Impact factor: 4.939

3.  Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV naïve recipients.

Authors:  S L Orloff; Y-K Hwee; C Kreklywich; T F Andoh; E Hart; P A Smith; I Messaoudi; D N Streblow
Journal:  Am J Transplant       Date:  2011-01       Impact factor: 8.086

4.  Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants.

Authors:  Daniel N Streblow; Craig Kreklywich; Qiang Yin; V T De La Melena; Christopher L Corless; Patricia A Smith; Christina Brakebill; Judith W Cook; Cornelis Vink; Cathrien A Bruggeman; Jay A Nelson; Susan L Orloff
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  Human cytomegalovirus induces TGF-β1 activation in renal tubular epithelial cells after epithelial-to-mesenchymal transition.

Authors:  Masako Shimamura; Joanne E Murphy-Ullrich; William J Britt
Journal:  PLoS Pathog       Date:  2010-11-04       Impact factor: 6.823

6.  The effect of cytomegalovirus infection on acute rejection in kidney transplanted patients.

Authors:  Boshra Hasanzamani; Maryam Hami; Vajihe Zolfaghari; Mahtab Torkamani; Mahin Ghorban Sabagh; Saiideh Ahmadi Simab
Journal:  J Renal Inj Prev       Date:  2016-05-16

7.  Cytomegalovirus Viremia after Living and Deceased Donation in Kidney Transplantation.

Authors:  Ulrich Jehn; Katharina Schütte-Nütgen; Joachim Bautz; Hermann Pavenstädt; Barbara Suwelack; Gerold Thölking; Hauke Heinzow; Stefan Reuter
Journal:  J Clin Med       Date:  2020-01-17       Impact factor: 4.241

8.  Clinical consequences of primary CMV infection after renal transplantation: a case-control study.

Authors:  Ramandeep Singh; Hessel Peters-Sengers; Ester B M Remmerswaal; Unsal Yapici; Karlijn A M I van der Pant; Neelke C van der Weerd; Joris J T H Roelofs; René A W van Lier; Fréderike J Bemelman; Sandrine Florquin; Ineke J M Ten Berge
Journal:  Transpl Int       Date:  2020-07-04       Impact factor: 3.782

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.